Impact of Transcranial Direct Current Stimulation on the Capacity to Perform Burpees

NCT ID: NCT06472882

Last Updated: 2024-06-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-01-06

Study Completion Date

2024-04-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Introduction and Background:

Transcranial direct current stimulation (tDCS) has emerged as a potential intervention to improve physical performance. The primary aim of this study is to investigate the effects of tDCS applied to the primary motor cortex (M1) and dorsolateral prefrontal cortex (DLPFC) on performance in a maximal effort task, specifically the No Jump Burpee exercise.

Study Design:

This study will utilize a double-blind crossover design, where each subject will complete three experimental conditions: a-DLPFC, a-M1, and SHAM.

Participants:

Twenty healthy male subjects will be recruited for the study.

Intervention:

Each participant will undergo three conditions in a randomized order:

a-DLPFC: tDCS applied to the dorsolateral prefrontal cortex.

a-M1: tDCS applied to the primary motor cortex. SHAM: Placebo stimulation.

Procedure:

Prior to performing the No Jump Burpee exercise to exhaustion, tDCS will be administered at a current of 2 milliampere (mA) for 20 minutes.

Measurements:

The following variables will be measured during the exercise:

Total number of repetitions of the No Jump Burpee exercise. Vastus lateralis muscle oxygen saturation. Heart rate. Subjective perception of exertion (RPE).

Data Analysis:

Repeated measures ANOVAs will be used to analyze the effects of the different tDCS conditions on the performance outcomes.

Ethical Considerations:

The study protocol will be reviewed and approved by an appropriate ethics committee. Written informed consent will be obtained from all participants before participation in the study.

Objectives:

The primary objective is to evaluate the impact of tDCS on physical performance, specifically measuring the total number of repetitions of the No Jump Burpee exercise. Secondary objectives include assessing the changes in muscle oxygen saturation, heart rate, and subjective perception of exertion.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Transcranial Direct Current Stimulation Dorsolateral Prefrontal Cortex Primary Motor Cortex

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

The study applied a double-blind, crossover design to examine the viability of tDCS in improving performance during a maximal effort task, particularly the "No Jump Burpee" exercise.
Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

DOUBLE

Participants Investigators
To ensure a double-blind design, the researcher who administered the tDCS was not present during the physical measurements, and the evaluator responsible for the physical measurements was unaware of the type of tDCS received by the participant. In this way, participants and evaluators remained blinded to the treatment administered.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

tDCS Targeting the Dorsolateral Prefrontal Cortex (DLPFC)

Participants in this arm will receive transcranial Direct Current Stimulation (tDCS) targeting the DLPFC. The tDCS will be administered at an intensity of 2 mA for 20 minutes. This arm aims to evaluate the effects of DLPFC stimulation on performance during a maximal effort "No Jump Burpee" exercise.

Group Type EXPERIMENTAL

tDCS targeting DLPFC

Intervention Type DEVICE

The anodic electrode will be placed on the left DLPFC (area F3) and the cathode on the right orbitofrontal cortex (area Fp2). Participants will receive 20 minutes of tDCS at 2 mA while seated.

tDCS Targeting the Primary Motor Cortex (M1)

Participants in this arm will receive transcranial Direct Current Stimulation (tDCS) targeting the primary motor cortex (M1). The tDCS will be administered at an intensity of 2 mA for 20 minutes. This arm aims to evaluate the effects of M1 stimulation on performance during a maximal effort "No Jump Burpee" exercise.

Group Type EXPERIMENTAL

tDCS targeting M1

Intervention Type DEVICE

The anodes will be placed over C3 and C4 (according to EEG 10-20 system), and the cathodes over the ipsilateral shoulders. Participants will receive 20 minutes of tDCS at 2 mA while seated.

SHAM tDCS

Participants in this arm will receive a sham tDCS session, which simulates the experience of tDCS without actual stimulation. This arm serves as a control to ensure the blinding of participants and evaluators.

Group Type SHAM_COMPARATOR

SHAM tDCS

Intervention Type DEVICE

The electrodes will be placed as in the other conditions, but the stimulation will be switched off after 30 seconds, providing an initial stinging sensation without continuous stimulation.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

tDCS targeting DLPFC

The anodic electrode will be placed on the left DLPFC (area F3) and the cathode on the right orbitofrontal cortex (area Fp2). Participants will receive 20 minutes of tDCS at 2 mA while seated.

Intervention Type DEVICE

tDCS targeting M1

The anodes will be placed over C3 and C4 (according to EEG 10-20 system), and the cathodes over the ipsilateral shoulders. Participants will receive 20 minutes of tDCS at 2 mA while seated.

Intervention Type DEVICE

SHAM tDCS

The electrodes will be placed as in the other conditions, but the stimulation will be switched off after 30 seconds, providing an initial stinging sensation without continuous stimulation.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy subject.
* No use of any ergogenic substance.
* Participants must be recreationally active, defined as engaging in moderate physical activity at least 3 times per week for the past 6 months

Exclusion Criteria

* Any contraindications to transcranial Direct Current Stimulation, such as metallic implants in the head, active implanted medical devices (e.g., pacemakers), or skin conditions affecting the scalp.
* Current or recent (within the past 6 months) substance abuse, including alcohol or recreational drugs.
* Musculoskeletal injury within the past 6 weeks.
* Lower extremity pain above 3 or more according to numeric pain scale.
* History of epilepsy or convulsive crisis.
Minimum Eligible Age

18 Years

Maximum Eligible Age

35 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of A Coruna, La Coruna, Spain

UNKNOWN

Sponsor Role collaborator

Universidad Católica San Antonio de Murcia

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Salvador Romero Arenas

Ph.D.

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Catholic University of Murcia

Guadalupe, Murcia, Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Spain

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PID2021-128204OA-I00-AEI/FEDER

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

ED431B 2021/28

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

CE-031908-A

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.